Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07568145 · ClinicalTrials.gov registry record · NA
The PREVENT Resilience Study
A NA study, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07568145 is a NA study that is actively recruiting participants, run by Emory University. The registered enrollment target is 50 participants.
The verdict
NCT07568145, a NA study, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
PTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of PTSD and depression, which can persist for years. The early weeks following trauma present a unique opportunity to deliver early interventions that can prevent chronic PTSD and depression from occurring, and the researchers propose a brain-based intervention that will reduce reactivity to threat, an early risk mechanism for chronic PTSD. This study is being done to learn more about whether brain stimulation in the weeks after a trauma can change brain activity that is linked to Post-Traumatic Stress Disorder (PTSD).
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
- OTHER TMS Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-18 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07568145
The ClinicalTrials.gov registry entry for NCT07568145 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT07568145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07568145 about?
NCT07568145 is a clinical study titled "The PREVENT Resilience Study". PTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of PTSD and depression, which can persist for years. ...
What is the current status of trial NCT07568145?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06-18. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07568145?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE), TMS Sham (OTHER).
Who is sponsoring clinical trial NCT07568145?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.